BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020

Mar 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-03-16

Reporting Person: LAWLIS V BRYAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-16	Common Stock	S	4610	$76.52	Disposed	18980	Direct
2020-03-17	Common Stock	M	3750	$21.51	Acquired	22730	Direct
2020-03-17	Common Stock	S	3750	$75.39	Disposed	18980	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-17	Stock Option (Right to buy Common Stock)	$21.510	M	3750	Disposed	2020-05-11	Common Stock (3750)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on January 16, 2020.

F2: Trade made pursuant to a 10b5-1 plan executed on May 1, 2019.

F3: Reflects the number of options outstanding after the transactions from the specific stock option grant.